Clinical Trial to Determine Tolerable Dosis of Vorinostat in Patients With Mild Alzheimer Disease

Clinical trial NCT03056495 · TERMINATED

Trial details

NCT number: NCT03056495
Sponsor: German Center for Neurodegenerative Diseases (DZNE)
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2017-09-28
Primary completion: 2024-03-04
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.